Citation: | ZHANG Jing, WANG Zhifeng, KE Meiyun, FANG Xiucai, LI Xiaoqing, ZHANG Jiachang, SHU Ke, SUN Xiaohong. Analysis and comparison of impedance-pH monitoring parameters in diagnosis of GERD based on the "Lyon Consensus"[J]. Chinese Journal of General Practice, 2024, 22(3): 380-383. doi: 10.16766/j.cnki.issn.1674-4152.003407 |
[1] |
KATZKA D A, KAHRILAS P J. Advances in the diagnosis and management of gastroesophageal reflux disease[J]. BMJ, 2020, 371: m3786. DOI: 10.1136/bmj.m3786.
|
[2] |
周金池, 赵曙光, 王新, 等. 中国部分地区基于社区人群胃食管反流病患病率Meta分析[J]. 胃肠病学和肝病学杂志, 2020, 29(9): 1012-1020. doi: 10.3969/j.issn.1006-5709.2020.09.012
ZHOU J C, ZHAO S G, WANG X, et al. Meta-analysis of the prevalence of gastroesophageal reflux disease based on community population in some areas of China[J]. Chinese Journal of Gastroenterology and Hepatology, 2020, 29(9): 1012-1020. doi: 10.3969/j.issn.1006-5709.2020.09.012
|
[3] |
VISAGGI P, DEL CORSO G, GYAWALI C P, et al. Ambulatory pH-impedance findings confirm that grade B Esophagitis provides objective diagnosis of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2023, 118(5): 794-801. doi: 10.14309/ajg.0000000000002173
|
[4] |
RUSU R I, FOX M R, TUCKER E, et al. Validation of the Lyon classification for GORD diagnosis: acid exposure time assessed by prolonged Wireless pH-monitoring in healthy controls and patients with erosive oesophagitis[J]. Gut, 2021, 70(12): 2230-2237. doi: 10.1136/gutjnl-2020-323798
|
[5] |
GYAWALI C P, KAHRILAS P J, SAVARINO E, et al. Modern diagnosis of GERD: the Lyon Consensus[J]. Gut, 2018, 67(7): 1351-1362. doi: 10.1136/gutjnl-2017-314722
|
[6] |
NETO R M L, HERBELLA F A M, SCHLOTTMANN F, et al. Does DeMeester score still define GERD?[J]. Dis Esophagus, 2019, 32(5): doy118. DOI: 10.1093/dote/doy118.
|
[7] |
GYAWALI C P, YADLAPATI R, FASS R, et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0[J]. Gut, 2024, 73(2): 361-371. doi: 10.1136/gutjnl-2023-330616
|
[8] |
任梦华, 孙淑珍, 王红建, 等. 经口内镜下贲门缩窄术治疗反流性食管炎效果分析[J]. 中华实用诊断与治疗杂志, 2022, 36(8): 841-844. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202208020.htm
REN M H, SUN S Z, WANG H J, et al. Efficacy of peroral endoscopic cardial constriction on reflux esophagitis[J]. Journal of Chinese Practical Diagnosis and Therapy, 2022, 36(8): 841-844. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202208020.htm
|
[9] |
陈琰, 隋昕珂, 黄鑫, 等. 反流性食管炎患者食管外症状的危险因素分析[J]. 解放军医学杂志, 2021, 46(8): 808-811. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202108011.htm
CHEN Y, SUI X K, HUANG X, et al. Clinical study of risk factors associated with extraesophageal symptoms in patients with reflux esophagitis[J]. Medical Journal of Chinese People ' s Liberation Army, 2021, 46(8): 808-811. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202108011.htm
|
[10] |
于爱萍, 董新华, 李珂, 等. 腹腔镜Nissen与Toupet胃底折叠术治疗难治性胃食管反流病的效果比较[J]. 中国实用医刊, 2021, 48(22): 1-4.
YU A P, DONG X H, LI K, et al. Comparison of effects of laparoscopic Nissen versus Toupet fundoplication in the treatment of refractory gastroesophageal reflux disease[J]. Chinese Journal of Practical Medicine, 2021, 48(22): 1-4.
|
[11] |
吴国丽, 邱晶, 李晓慧, 等. 逍遥丸联合兰索拉唑治疗老年胃食道反流病的疗效及对胃肠激素的影响[J]. 药物评价研究, 2020, 43(7): 1335-1338. https://www.cnki.com.cn/Article/CJFDTOTAL-YWPJ202007023.htm
WU G L, QIU J, LI X H, et al. Efficacy of Xiaoyao Pills combined with lansoprazole in treatment of senile gastroesophageal reflux disease and its effect on gastrointestinal hormones[J]. Drug Evaluation Research, 2020, 43(7): 1335-1338. https://www.cnki.com.cn/Article/CJFDTOTAL-YWPJ202007023.htm
|
[12] |
ROMAN S, GYAWALI C P, SAVARINO E, et al. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group[J]. Neurogastroenterol Motil, 2017, 29(10): 1-15.
|
[13] |
HOSHINO M, OMURA N, YANO F, et al. Comparison of the multichannel intraluminal impedance pH and conventional pH for measuring esophageal acid exposure: a propensity score-matched analysis[J]. Surg Endosc, 2017, 31(12): 5241-5247. doi: 10.1007/s00464-017-5595-9
|
[14] |
STREETS C G, DEMEESTER T R. Ambulatory 24-hour esophageal pH monitoring: why, when, and what to do[J]. J Clin Gastroenterol, 2003, 37(1): 14-22. doi: 10.1097/00004836-200307000-00007
|
[15] |
ANG D, XU Y, ANG T L, et al. Wireless oesophageal pH monitoring: establishing values in a multiracial cohort of asymptomatic Asian subjects[J]. Dig Liver Dis, 2013, 45(5): 371-376. doi: 10.1016/j.dld.2012.11.014
|
[16] |
HASAK S, YADLAPATI R, ALTAYAR O, et al. Prolonged Wireless pH monitoring in patients with persistent reflux symptoms despite proton pump inhibitor therapy[J]. Clin Gastroenterol Hepatol, 2020, 18(13): 2912-2919. doi: 10.1016/j.cgh.2020.01.031
|
[17] |
SIFRIM D, ROMAN S, SAVARINO E, et al. Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world[J]. Gut, 2021, 70(8): 1441-1449. doi: 10.1136/gutjnl-2020-322627
|
[18] |
GYAWALI C P, TUTUIAN R, ZERBIB F, et al. Value of pH impedance monitoring while on twice-daily proton pump inhibitor therapy to identify need for escalation of reflux management[J]. Gastroenterology, 2021, 161(5): 1412-1422. doi: 10.1053/j.gastro.2021.07.004
|
[19] |
SPECHLER S J, HUNTER J G, JONES K M, et al. Randomized trial of medical versus surgical treatment for refractory heartburn[J]. N Engl J Med, 2019, 381(16): 1513-1523. doi: 10.1056/NEJMoa1811424
|